E13.1

Other specified diabetes mellitus with ketoacidosis

Non-billable header

E13.1 is a non-billable header code. Use one of the more specific codes below.

Inclusion terms

diabetes mellitus due to genetic defects of beta-cell function
diabetes mellitus due to genetic defects in insulin action
postpancreatectomy diabetes mellitus
postprocedural diabetes mellitus
secondary diabetes mellitus NEC
Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Not coded here — never report together with this code.

transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E13)
diabetes (mellitus) due to autoimmune process (E10.-) (from E13)
diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-) (from E13)
diabetes mellitus due to underlying condition (E08.-) (from E13)
drug or chemical induced diabetes mellitus (E09.-) (from E13)
gestational diabetes (O24.4-) (from E13)
neonatal diabetes mellitus (P70.2) (from E13)
type 1 diabetes mellitus (E10.-) (from E13)

Add a code to identify the following, if applicable.

code to identify control using: (from E13)
injectable non-insulin antidiabetic drugs (Z79.85) (from E13)
insulin (Z79.4) (from E13)
oral antidiabetic drugs (Z79.84) (from E13)
oral hypoglycemic drugs (Z79.84) (from E13)